New publication reports U.S. compassionate use of denovoSkin™ in pediatric reconstructive surgery

A new peer-reviewed report in the Journal of Burn Care & Research describes the compassionate use of denovoSkin™ in a pediatric patient with extensive burn injuries treated at Massachusetts General Hospital (Boston, USA).

The publication details reconstructive procedures including contracture release and treatment of unstable scars, reporting high engraftment rates, durable healed skin, and handling characteristics comparable to full-thickness autografts.

This report provides additional clinical detail following the first U.S. compassionate use announced in 2024 and the abstract presented in 2025.

In parallel, CUTISS continues to advance denovoSkin™ in an ongoing Phase 3 clinical trial in the European Union (8 countries) and Switzerland for adult and adolescent patients with severe burns. Our clinical development pipeline is available here.

The published report can be accessed online here.